Analysts Set Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) PT at $16.00

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) has been given a consensus rating of “Hold” by the five brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $16.00.

Several equities research analysts recently weighed in on the company. Wall Street Zen cut Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Maxim Group started coverage on shares of Neonc Technologies in a research note on Monday, May 18th. They set a “buy” rating and a $20.00 target price on the stock. Weiss Ratings cut Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, June 24th. Alliance Global Partners initiated coverage on shares of Neonc Technologies in a research note on Tuesday, May 19th. They set a “buy” rating and a $13.00 target price for the company. Finally, BTIG Research restated a “buy” rating and set a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, May 26th.

Insider Buying and Selling at Neonc Technologies

In other news, CEO Amir F. Heshmatpour purchased 9,000 shares of Neonc Technologies stock in a transaction that occurred on Tuesday, August 18th. The stock was bought at an average price of $5.54 per share, with a total value of $49,860.00. Following the completion of the transaction, the chief executive officer directly owned 3,096,000 shares of the company’s stock, valued at approximately $17,151,840. The trade was a 0.29% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have purchased a total of 24,000 shares of company stock worth $108,450 over the last ninety days.

Hedge Funds Weigh In On Neonc Technologies

Hedge funds have recently bought and sold shares of the business. Barclays PLC boosted its holdings in shares of Neonc Technologies by 5,314.8% during the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after acquiring an additional 8,982 shares during the last quarter. Goldman Sachs Group Inc. purchased a new position in shares of Neonc Technologies in the 4th quarter worth $124,000. OMERS ADMINISTRATION Corp purchased a new position in Neonc Technologies in the fourth quarter worth about $126,000. Global Retirement Partners LLC purchased a new position in shares of Neonc Technologies in the second quarter worth approximately $126,000. Finally, Royal Bank of Canada bought a new stake in Neonc Technologies during the first quarter valued at approximately $247,000.

Neonc Technologies Trading Down 16.3%

NTHI opened at $4.63 on Friday. The stock has a 50-day moving average price of $4.14 and a 200-day moving average price of $5.99. Neonc Technologies has a 12-month low of $3.01 and a 12-month high of $12.99.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.